Design Therapeutics (DSGN) Change in Accured Expenses (2020 - 2021)
Historic Change in Accured Expenses for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$26000.0.
- Design Therapeutics' Change in Accured Expenses fell 10360.11% to -$26000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.4 million, marking a year-over-year increase of 6909.09%. This contributed to the annual value of -$1.2 million for FY2024, which is 216.69% up from last year.
- Per Design Therapeutics' latest filing, its Change in Accured Expenses stood at -$26000.0 for Q4 2021, which was down 10360.11% from $1.4 million recorded in Q3 2021.
- In the past 5 years, Design Therapeutics' Change in Accured Expenses ranged from a high of $2.5 million in Q3 2020 and a low of -$1.8 million during Q1 2020